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ABSTRACT 
Introduction:  Parkinson's Disease (PD) is a progressive neurological disorder caused by a loss of pigmented 
dopaminergic neurons of the substantia nigra pars compacta. The major manifestations of the disease consist of 
resting tremor, rigidity, bradykinesia and gait disturbances. Before the advent of Levodopa surgery was main stay 
of treatment of PD. Medical therapy is still the mainstay of treatment for Parkinson's diseasebut its prolonged use 
results in side effects like drug induced dyskinesia. In 1952 Dr. Lars Leksell introduced Pallidotomy that was 
successful in relieving many Parkinsonian symptoms in patients. Later on thalamotomy became widely accepted, 
replacing pallidotomy as the surgical treatment of choice for Parkinson's Disease. Thalamotomy had an excellent 
effect on the tremor, was not quite as effective at reducing rigidity rather bradykinesia was often aggravated by 
the procedure. 
Objective:  Effectiveness of Pallidotomy in rigidity in medically refractory Parkinson’s disease and its 
complications. 
Study Design:  Descriptive prospective case series. 
Setting of study:  Department of Neurosurgery, Lahore General Hospital, Lahore. 
Duration:  June 2013 to April 2016. 
Materials and Methods:  Patients of Parkinson’s disease with predominant component of muscular rigidity 
despite maximum medical therapy admitted through outdoor department. Detailed history and physical exami-
nation was done. Grading of muscular rigidity was done by applying UPDRS score Rigidity part 22. Secondary 
Parkinsonism was ruled out with the help of CT scan and MRI brain. Surgery was performed after informed 
consent. 
Results:  Twenty patients were included in the study with no lost to follow up. There were 14 (70%) male and 6 
(30%) female patients. Mean age of the patients was 47.58 ± 8.69 years. There were 11 (55%) left sided 
procedures and 9 (45%) right sided Pallidotomy procedures performed. Mean pre-operative rigidity using 
UPRDS was 24.9 ± 1.47, while post-operative score was 11.87 ± 1.53. Pallidotomy procedure in our study had no 
mortality but 4 (20%) patients suffered from procedure related complications one patient (5%) had transient 
hemiparesis, 1 (5%) suffered from wound infection, 1 (5%) having dysarthria and 1 (5%) transient diplopia. 
Conclusion:  Pallidotomy is effective as well as safe surgical treatment option in reducing rigidity for medically 
refractory Parkinsonism’s Disease. 
Key words:  Parkinson’s disease, dyskinesia, rigidity, medically refractory. 
Abbreviations:  PD: Parkinson’s Disease. 
 
INTRODUCTION 
Parkinson disease (PD) is one of the most common 
neurologic disorders, affecting approximately 1% of 
individuals older than 60 years. It causes progressive 
disability that can be slowed, but not halted, by treat-
ment. The classic motor features of Parkinson disease 
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typically start insidiously and emerge slowly over 
weeks or months. The 3 cardinal signs of Parkinson 
disease are resting tremor, rigidity, and bradykinesia. 
Postural instability is sometimes considered as the 
fourth cardinal feature. 
 The basal ganglia motor system modulates the 
cortical output necessary for normal body movements. 
Signals from the cerebral cortex are processed through 
the basal ganglia – thalamocortical motor pathway and 
return to cerebral cortex via a feedback pathway.The 
direct and indirect pathways exist within the basal 
ganglia circuit. In Parkinson disease, decreased striatal 
dopamine causes increased inhibitory output from the 
Globus Pallidus internus/substantianigra pars reticulate 
(GPi/SNr) via both the direct and indirect pathways. 
The increased inhibition of the thalamocortical path-
way suppresses movement.
1
 
 In the early 1900s, surgical treatment of Parkin-
son's Disease was common. A variety of operations 
targeted at destroying certain areas of the brain were 
tried in an attempt to relieve severe tremor and rigi-
dity. In 1952 Dr. Lars Leksell introduced Pallidotomy 
for treating Parkinsonian symptoms.At the same time, 
thalamotomy became widely accepted, replacing 
pallidotomy as the surgical treatment of choice for PD. 
Thalamotomy had good control of tremor but was not 
effective at reducing rigidity; bradykinesia was often 
aggravated.In 1985, Dr. Lauri Laitinenre – introduced 
the pallidotomy, as a treatment for patients who had 
previously undergone thalamotomy but remained 
symptomatic.After 1992 encouraging experience of 
Lauri prompted other specialists to re-examine the role 
of pallidotomy in PD.Stereotactic pallidotomy being 
ablative procedure is not without certain surgical risks. 
 
OBJECTIVES 
Effectiveness of Pallidotomy in rigidity of medically 
refractory Parkinson’s disease and its complications. 
 
Operational Definitions 
Effectiveness:  Reduction in rigidity, grade 1 or more 
from base line, after pallidotomy measured by Unified 
Parkinson Disease Rating Score part 22 after 3 
months. 
 
Muscle Rigidity:  resistance to passive movements of 
muscles measured with UPDRS part 22, grade 0 to 4. 
 
Medical Refractory:  PD patients getting maximum
dose of carbidopa (200 mg/day and levodopa 800 
mg/day) for 6 months and have rigidity grade ≥ 2. 
 
MATERIAL AND METHODS 
Study Design 
Prospective Descriptive case series study. 
 
Setting 
Department of Neurosurgery, Postgraduate Medical 
Institute / Lahore General Hospital, Lahore. 
 
Duration of Study 
June 2013 to April 2016. 
 
Sample Size 
20 patients were included in this study. 
 
Sampling Technique 
It was Non probability consecutive sampling. 
 
Inclusion Criteria 
1. Adult population of both sexes having muscles 
rigidity grade 2 to grade 4due to medical refrac-
tory Parkinson’s disease. 
 
Exclusion Criteria 
1. Muscle rigidity due to stroke/ infarction, demyeli-
nation, trauma seen as hypodense  area on CT or 
hyper intense on MRI. 
2. Lesion in Basal ganglia on MRI 
 
Data Analysis 
All the collected data was entered and analyzed using 
IBM SPSS Statistics version 22. The qualitative data 
like demographics (Gender) was presented as per-
centage and frequency distribution tables. The Quan-
titative data like age was presented in Mean ± S.D. 
 After fulfilling the parametric test assumptions, 
Paired sample t-test was used to determine the sig-
nificance differences before and after treatment in 
UPDRS score. The complications were noted and pre-
sented as percentages. The p value of ≤ 0.05 was taken 
as significant. 
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Operative Technique 
Antiparkinsonian medicine/s stopped 12 hours before 
procedure and kept patients nil by mouth for 6 hours. 
Under local anesthesia Leksell G stereotactic frame 
was applied followed by MRI brain plain and contrast. 
MRI brain images were transferred to Elekta Surgi-
planto calculate anterior and posterior commissure, x, 
y, z coordinates and trajectory.After getting measure-
ments of coordinates all frame attachments were 
adjusted on operation table. Surgical site was painted 
with povidine iodide solution and draping done. Drap-
ing is done in such a way that intraoperative assess-
ment of the patients could be made i.e. patients eyes 
and face were not covered. Incision made at marked 
site under local anesthetic infiltration and 12mm burr 
hole made. The dura is coagulated and opened in 
cruciate fashion. Stereotactic frame adjusted and 
brought in positioned and the macroelectrode of 2.1 
mm diameter with un-insulated tip was passed through 
burr hole. The electrode was placed at a point 4 mm 
above the target and macrostimulation was started by 
Cosman G Radiofrequency Lesion Generator. Macro-
stimualation was used to get optimal target location. 
On macrostimulation adverse effects like contractions 
of fingers, facial deviation, visual hallucination, and 
slurred speech were cautiously examined by Neurolo-
gist along with therapeutic effects like decreased in 
rigidity by pronation and supination, flexion and 
extension at elbow joint, bradykinesia by tapping of 
index finger and thumb. Problems in speech were also 
assessed during stimulation by asking the patient to 
repeat words or answer the simple question and 
observing any difficulties. Gradual increase in voltage 
from low to high stimulation was used to check pro-
ximity to optic nerve, internal capsule and any speech 
dysfunction. Same steps are repeated to go down each 
millimeter to find optimal target. Lesion madeon target 
at 1.5 volt, temperature 60 to 90 degree °F for 60 
seconds. After lesioning electrode withdrawn slowly 
and wound closed in layers. For bilateral Pallidotomy 
same procedure is repeated on other side. Patients 
were advised to continue with their preoperative anti-
parkinsonian medications and analgesics and antibio-
tic. Assessment of the patient’s rigidity, bradykinesia 
and dyskinesia were observed immediate post-opera-
tively. On the first postoperative day the patients were 
assessed by the neurologist and the neurosurgeon and 
on satisfaction of both clinicians patients were dis-
charged on first post-operative day. 
 Stitches were removed on fifth postoperative day. 
Follow-up visits were scheduled after 3 weeks and 
then after 3 months to assess improvement in reduct-
ion in muscular rigidity. 
 
RESULTS 
In this study mean age of the patients was 47.58 ± 8.69 
years. In this study 14 (70%) were male and 6 (30%) 
were female. 
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Fig. 1:  Gender. 
 
 In this study 5 (25%) patients were below 40 years 
of age, 6 (30%) were between 40 to 50 years of age 
and 9 (45%) were aged more than 50 years of age. 
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Fig. 2:  Age Distribution. 
 
 There were 11 (55%) left sided procedures and 9 
(45%) right sided Pallidotomy procedures were 
performed. Mean pre-operative rigidity using UPRDS 
was 24.9 ± 1.47, while post-operative score was 11.87 
± 1.53. Application of t-test (41.223) Pre and Post 
…… Linear (Age) 
…… Linear (Age) 
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Parkinsonian rigidity score was statistically significant 
(p < 0.001). 
 There was a statistically significant difference 
between Pre op and 3, 6 weeks and 3 months post op 
Parkinsonian rigidity using UPRDS (Table 2). There 
was also statistically significant difference between 
post op and 3, 6 and 3 months post op Parkinsonian 
rigidity using UPRDS (Table 3). There was numeri-
cally difference between 6 week and 3 months post 
operative UPRDS score but that not reached to statis-
tical significance (Table 4). 
 Pallidotomy procedure in our study had no mor-
tality but 4 (20%) patients suffered from procedure 
related complications one patient (5%) suffered from 
transient hemiparesis, 1 (5%) from wound infection, 1 
(5%) having dysarthria and 1 (5%) transient diplopia. 
 
DISCUSSION 
Parkinson's Disease (PD) is a common neurodege- 
nerative disorder. Symptoms of PD can be pharma-
Table 1:  Showing Disease Pattern Distribution. 
 
 
Frequency 
Bilateral rigidity, Bradykinesia 5 
Bilateral rigidity more on Right side 4 
Bilateral Rigidity more on Left side 3 
Bilateral rigidity, Bradykinesia, Ataxia  4 
Difficulty Walking, Micrographia, 
Bradykinesia, Bilateral Rigidity  
4 
 
Comparison of Pre and Post op. Parkinsonian rigidity 
using UPRDS. 
 
 Mean Standard Deviation 
pre-op 24.9   1.47 
post-op 11.87 1.53 
 
cologically treated with drugs like le-
vodopa. Surgery is option for patients 
who have advanced disease that is 
either refractory to pharmacotherapy 
or develop side effects like disabling 
dyskinesia. 
 Now more and more literature on 
neuromodulation therapy for PD is 
mushrooming using more advanced 
and sophisticated equipment and gad-
gets like DBS but in 1990s, publicat-
ions on long term results of pallido-
tomy in treatment of PD rigidity and 
tremors actually reopened the door for 
functional neurosurgery.
7
 Moreover 
pallidotomy still holds its importance 
in developing countries where cost 
effectiveness of procedure does mat-
ter. The main argument against les-
ioning therapies for Parkinsonian rigi-
dity and tremors like pallidotomy or 
thalamotomy is their irreversibility. 
There are certain situations like imp-
lant induced infection, non affor-
dibility favors more towards lesioning 
procedures. PD is a ongoing process 
and in certain cases people survive up 
to that advanced age that discussion 
arises about the cost effectiveness of 
revision of battery and social benefits
 
Table 2: Comparison of Pre and Follow up post op Parkinsonian 
rigidity score. 
 
 Mean Std. Deviation T test p value 
Pre Operative Score 24.9 1.47   
3 Weeks 11.27 1.39 42.633 < 0.001 
6 Weeks 10.67 1.03 46.542 < 0.001 
3 Months 10.47 .860 46.077 < 0.001 
 
Table 3: Comparison of post-operative and Follow up post op 
Parkinsonian rigidity score. 
 
 Mean Std. Deviation T test p value 
Post Operative Score 11.87 1.53   
3 Weeks 11.27 1.39 4.539 < 0.001 
6 Weeks 10.67 1.03 9.893 < 0.001 
3 Months 10.47 0.860 5.279 < 0.001 
 
Table 4: Comparison of 6 weeks post op and 3 months post op 
Parkinsonian rigidity using UPRDS. 
 
 Mean Std. Deviation T test p value 
6 Weeks 10.67 1.03 
1.00 0.326 
3 Months 10.47 .860 
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of that particular person, as Parkinson’s disease is not 
only decline in and degeneration of motor circuits but 
also in memory and cognition of patient. In these cases 
pallidotomy is still thought to be an effective augment-
tation in arsenal of different options of treatment of 
Parkinson’s disease. 
 Parkinson’s disease is well established disease of 
old and elderly age. 1% of population above 60 years 
of age are bound to have Parkinson’s disease. The 
cause is not well known but genetic and environmental 
factors are postulated to be the cause of this disease. 
Some evidences have been identified favoring familial 
aggregation of genetic material. The genetic factors 
are thought to be contributing only 10% in causing this 
disease leaving main chunk of 90% as an etiological 
factor to environmental factors.  These environmental 
factors include pesticide toxicity, heavy metal expo-
sure, diet, working in high magnetic fields, smoking, 
water supply, exposure to urban lifestyle etc
3
. Pring-
sheimet al published meta-analysis of the worldwide 
data showed a rising prevalence of PD with age (all 
per 100,000): 41 in 40 to 49 years; 107 in 50 to 59 
years; 173 in 55 to 64 years; 428 in 60 to 69 years; 425 
in 65 to 74 years; 1087 in 70 to 79 years; and 1903 in 
older than age 80
2
. Its onset before 40 years is rare 
according to the studies but in this study 5 (25%) 
patients were below age 40. Mean age of presentation 
in this study was 47.58 years.Younger onset of disease 
is associated with more motor complications and 
disease severity.
4
 This evidence provokes some serious 
questions about the environmental hazards and acq-
uired factors in studied population. 
 Gender also cause a great difference in prevalence 
of PD as universally male are1.5-2 times more effected 
than female.Also the disease manifests at a later age in 
women by a mean of 2.2 years. Women with PD may 
have better motor scores, but there is higher preva-
lence of dyskinesias. These gender differences are 
attributed to differences in life style and hormonal 
factors and also differences in exposure to risk factors 
for PD.
5
 In our study male to female ratio was 2.3:1. 
 Patients with different stages of Parkinson’s dis-
ease and different UPDRS rigidity score were included 
in this study. Fourteen patients (70%) presented with 
UPDRS rigidity score 3 and 6 patients (30%) with 
rigidity score 4. After lesioning assessment of patients 
were done by UPDRS rigidity score on first post-
operative day and after three months. There was mar-
ked reduction in rigidity subjectively and objectively. 
Mean UPDRS score for rigidity at admission was 
3.507 and on follow-up after three months mean UP-
DRS score for rigidity was 1.346. There was improve-
ment in UPDRS score in term of reduction in rigidity 
was 2.161. In this study improvement in patients after 
pallidotomyin term of UPDRS was 47% on first post-
operative day and these scores continued to improve in 
the follow up period. Improvement continued upto3 
months. But statistical improvement of UPDRS was 
upto6 weeks. These findings are comparable with the 
previously published studies.de Bie RM et al reported 
in the "off' phase, the median UPDRS II score impro-
ved from 26.5 to 20.5 (23%) and the median UPDRS 
III score improved from 47.5 to 33.0 (31%).
6
Laitinen 
et al did pallidotomies in 38 patients and described 
almost complete relief of rigidity in 92% of the 
patients.
7 Dogali et al in 1995 described 60% improve-
ment after pallidotomy.
8 Schrag et al in 1999 described 
44% improvement in UPDRS postoperatively after 
pallidotomy.
9
 
 Complications published in literature for palli-
dotimies are visual field deficits, weakness, fatigue, 
hypersomnia, drooling, dysphagia, speech disorders, 
hiccups, hemorrhage, seizures, apraxia, coma, infect-
ion, mental confusion, and impaired memory.
10
 Bila-
teral procedures have more complications than uni-
lateral procedures.Pallidotomy procedure in our study 
had no mortality but 4 (20%) patients suffered from 
procedure related complications one patient (5%) suf-
fered from transient hemiparesis, 1 (5%) from wound 
infection, 1(5%) having dysarthria and 1 (5%) tran-
sient diplopia. 
 
CONCLUSION 
Pallidotomy is effective as well as safe surgical treat-
ment option in reducing rigidity for medically refra-
ctory Parkinsonism’s Disease where deep brain stimu-
lation is not feasible, affordable or available. 
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